The mu-opioid receptor gene polymorphism (A118G) alters HPA axis activation induced by opioid receptor blockade.
about
The role of the Asn40Asp polymorphism of the mu opioid receptor gene (OPRM1) on alcoholism etiology and treatment: a critical reviewGenetic susceptibility to heroin addiction: a candidate gene association studyAn evaluation of mu-opioid receptor (OPRM1) as a predictor of naltrexone response in the treatment of alcohol dependence: results from the Combined Pharmacotherapies and Behavioral Interventions for Alcohol Dependence (COMBINE) studyPersonality traits of agreeableness and extraversion are associated with ADH4 variationThe Neurobiology Shaping Affective Touch: Expectation, Motivation, and Meaning in the Multisensory ContextCortisol Stress Response in Men and Women Modulated Differentially by the Mu-Opioid Receptor Gene Polymorphism OPRM1 A118G.The long-term impact of early life pain on adult responses to anxiety and stress: Historical perspectives and empirical evidence.Association between single nucleotide polymorphisms in the mu opioid receptor gene (OPRM1) and self-reported responses to alcohol in American Indians.Genetic influences on response to alcohol and response to pharmacotherapies for alcoholism.Drug-induced and genetic alterations in stress-responsive systems: Implications for specific addictive diseases.Subjective health complaints in patients with lumbar radicular pain and disc herniation are associated with a sex - OPRM1 A118G polymorphism interaction: a prospective 1-year observational studyEffect of OPRM1 and stressful life events on symptoms of major depression in African American adolescentsTranslating the neuroscience of alcoholism into clinical treatments: from blocking the buzz to curing the blues.Human behavioral pharmacology, past, present, and future: symposium presented at the 50th annual meeting of the Behavioral Pharmacology Society.A genetic determinant of the striatal dopamine response to alcohol in menPharmacogenetics of alcohol and alcohol dependence treatmentNovel pharmacotherapeutic strategies for treatment of opioid-induced neonatal abstinence syndrome.Effects of opioid receptor gene variation on targeted nalmefene treatment in heavy drinkers.Alcoholism: genes and mechanisms.Nicotine withdrawal sensitivity, linkage to chr6q26, and association of OPRM1 SNPs in the SMOking in FAMilies (SMOFAM) sampleHaplotype block structure of the genomic region of the mu opioid receptor gene.Child μ-opioid receptor gene variant influences parent-child relations.Pharmacotherapy of addictions.Neurotransmitter and neuromodulator genes associated with a history of depressive symptoms in individuals with alcohol dependenceNo evidence of association between 118A>G OPRM1 polymorphism and heroin dependence in a large Bulgarian case-control sample.OPRM1 gene variation influences hypothalamic-pituitary-adrenal axis function in response to a variety of stressors in rhesus macaques.Naloxone-induced cortisol predicts mu opioid receptor binding potential in specific brain regions of healthy subjectsMultiple OPR genes influence personality traits in substance dependent and healthy subjects in two American populationsImpact of prospectively determined A118G polymorphism on treatment response to injectable naltrexone among methamphetamine-dependent patients: an open-label, pilot study.Pharmacogenetic aspects of addictive behaviorsPharmacological consequence of the A118G μ opioid receptor polymorphism on morphine- and fentanyl-mediated modulation of Ca²⁺ channels in humanized mouse sensory neurons.Genetic influences on the dynamics of pain and affect in fibromyalgia.Pharmacogenetics of naltrexone in asian americans: a randomized placebo-controlled laboratory study.CGRP 4218T/C polymorphism correlated with postoperative analgesic effect of fentanylThe relationship between naloxone-induced cortisol and delta opioid receptor availability in mesolimbic structures is disrupted in alcohol-dependent subjectsAddiction pharmacogenetics: a systematic review of the genetic variation of the dopaminergic systemOPRM1 gene variants modulate amphetamine-induced euphoria in humansPharmacogenetic approaches to the treatment of alcohol addiction.Serotonin transporter polymorphism, memory and hippocampal volume in the elderly: association and interaction with cortisol.Next-generation sequencing of human opioid receptor genes based on a custom AmpliSeq™ library and ion torrent personal genome machine
P2860
Q24616528-79E91FCB-2124-4ECE-85D5-3CFF6B091B70Q24634090-F9F3DBCC-1A56-451F-862E-EE6F83B0903FQ24645469-51A8992A-D97E-4A25-A598-6A32E1D35288Q24682299-52086730-37BD-4B06-98AB-612894778AC8Q26771487-01AD7123-F547-42C9-93B9-B5BCF94A9BECQ27311002-66F018C7-3F1D-4B1E-8F7E-5F0DAB5BE27BQ30366741-42134212-DB44-44C9-BCB0-832B1A42BEEBQ33330500-5B650D2B-E537-479B-B7AA-2F9DD1690A24Q33591091-E8D42FF7-6798-432B-A0B6-81355357D832Q33643136-F21716A0-3242-4BBF-A329-5F91FF6BA040Q33685100-7FB9EBE0-3462-4733-BD7D-9A9D4DA4ECBCQ33852618-F7434416-9125-4F1F-9A80-FF78988FA3EAQ33940215-F5419F4A-84B1-4B34-8636-454E850CFAADQ34033200-98E29BFA-1B4F-4C77-AD6C-E89ACFF2F877Q34077390-41E5073B-F90E-469A-B72E-9562F11DC47AQ34081709-2C670DC9-61DE-4AF3-8662-145324EBE2AAQ34081859-3F5DCDFC-CB4D-4B50-B640-504BD65A1E1BQ34180425-EE0A2144-25D3-4C21-8BA2-7562BF885EC1Q34374370-62D7B853-4876-4729-A488-316A02CA991EQ34614468-0734EE52-F0C8-4B0B-9B9F-24F86B1C9023Q34786964-08E479BB-FEEA-4439-9F1C-F40A113EBBE7Q34798577-905C8F0A-536C-4402-8F53-E6E527A05088Q34810395-E81B5418-40B4-4DDA-AC6F-807CDB0E199CQ35048215-9CD9A2B5-C2E5-4343-8752-E8EC9A9E7C94Q35083939-578617E7-BED7-48AA-BB4B-6B81D779DEC8Q35091270-4A080CBA-E898-4446-8EC5-10843BD2B16FQ35158874-E228BBD4-3A55-41F1-A226-4BE3B06A326FQ35182420-39DAA004-AE8F-4FA9-8541-486809A25AE5Q35220474-4689434C-A1C8-4774-BA85-C3F6CF804F7FQ35454787-84005B73-3646-4ED1-8CFB-48B35C8B67E4Q35464108-9CE9068D-4100-4CAC-BAED-62F5A9A8A48AQ35540410-C2294830-8911-4A30-930F-B2A6745B26FFQ35622645-0C6099F0-2B6D-4EE9-A288-058F6DF61492Q35854383-DDE4B637-070A-4DB0-9D1E-E2AC4417ACFDQ35916280-C8591813-F456-41E4-A188-10A697D32923Q35995415-0B199969-CA36-4A92-AD87-A056D4F504FEQ36039431-F4B8C778-DB38-4C9E-97E2-20686EC8135CQ36126591-71796AA2-B2A2-4E83-93A9-E7F01DA06A8FQ36157392-52F3D4E4-8C0D-450A-A8D2-2F235B3AA66FQ36159969-21E69D60-5AC1-43AC-B01C-E52D3536C2E9
P2860
The mu-opioid receptor gene polymorphism (A118G) alters HPA axis activation induced by opioid receptor blockade.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh-hant
name
The mu-opioid receptor gene po ...... d by opioid receptor blockade.
@en
The mu-opioid receptor gene polymorphism
@nl
type
label
The mu-opioid receptor gene po ...... d by opioid receptor blockade.
@en
The mu-opioid receptor gene polymorphism
@nl
prefLabel
The mu-opioid receptor gene po ...... d by opioid receptor blockade.
@en
The mu-opioid receptor gene polymorphism
@nl
P2093
P1476
The mu-opioid receptor gene po ...... d by opioid receptor blockade.
@en
P2093
Deidre Gotjen
Gary S Wand
Joanna Reynolds
Mary McCaul
Xioaju Yang
P304
P356
10.1016/S0893-133X(01)00294-9
P407
P577
2002-01-01T00:00:00Z
P6179
1038196330